SCHEMBL7879684

SCHEMBL7879684

CNC(N)=NC(=O)c1cc2ccc(Cl)cc2[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 7/20 0.64
HRH4 Q9H3N8 1/20 0.47
PDGFRB P09619 1/20 0.46
FLT3 P36888 1/20 0.46
F7 P08709 1/20 0.41
F3 P13726 1/20 0.41
DAO P14920 1/20 0.41
PYGL P06737 1/20 0.39
PYGM P11217 1/20 0.39
GPR183 P32249 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7884851 0.99 ALOX15 (0.63) ALOX15HRH4PDGFRBFLT3F7
SCHEMBL7877880 0.90 F7 (0.55) ALOX15HRH4FLT3F7F3
Hydrochloric Acid SCHEMBL7873363 0.88 F7 (0.54) ALOX15HRH4FLT3F7F3
SCHEMBL7882077 0.85 FLT3 (0.48) ALOX15PDGFRBFLT3DAOKDM4E
SCHEMBL7873687 0.85 HRH4 (0.48) ALOX15HRH4PDGFRBFLT3KDM4E
SCHEMBL7873330 0.85 HRH4 (0.46) ALOX15HRH4PDGFRBFLT3GRIN2D
Hydrochloric Acid SCHEMBL7882164 0.84 HRH4 (0.47) ALOX15HRH4FLT3KDM4EMEN1
Hydrochloric Acid SCHEMBL7881998 0.84 HRH4 (0.45) ALOX15HRH4PDGFRBFLT3GRIN2D
Hydrochloric Acid SCHEMBL7880750 0.84 FLT3 (0.47) ALOX15PDGFRBFLT3DAOKDM4E
SCHEMBL7877581 0.82 KDM4E (0.54) PDGFRBFLT3DAOKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed